NIH Reviewers: Doing Their Best

I believe the peer-review system is operating well. The concerns recently raised about peer review are a symptom of the lack of sufficient resources to fund all proposed meritorious science. For the past 12 years, I have served on multiple government and private foundation review panels and currently serve on the NIH Cellular Biology and Physiology II study section. Like all biomedical scientists, I, too, am competing for NIH and private foundation funding. It has been my experience that gran

Written byBrian Herman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For the past 12 years, I have served on multiple government and private foundation review panels and currently serve on the NIH Cellular Biology and Physiology II study section. Like all biomedical scientists, I, too, am competing for NIH and private foundation funding.

It has been my experience that grant reviewers are highly dedicated, hardworking, bright, objective individuals. I believe that the peer-review system is as impartial and fair as it can be, given that-as in any effort built upon human endeavor-mistakes can occur. All of us who sit on review panels understand and readily identify the enormous physical and emotional effort that goes into the preparation of a proposal and the anguish associated with the peer-review process, as our grants undergo that same peer-review process.

Grant proposals are submitted to the Division of Research Grants and are assigned to individual study sections by referral officers in consultation with scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies